Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil versus ripasudil in Japanese adults with POAG or ocular hypertension
jRCT2031200226Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Netarsudil arm with Ripasudil arm (2 arms). Primary endpoint: Mean diurnal intraocular pressure at Week 4. Started Nov 2020; status: completed.
02
Drugs
netarsudilripasudil
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on jRCT2031200226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200226.